This article was published on CannabisFN
DigiPath Inc. (OTCQB: DIGP), a leading provider of cannabis testing services through its DigiPath Labs subsidiary, recently announced that CEO Todd Denkin was interviewed on GFarmaTV – a leading YouTube channel covering the news, products, and lifestyleof the cannabis industry. In the video, Mr. Denkin provides GFarmaTV with a tour of its Las Vegas facility and explains how it partners with growers to test cannabis in batches.
According to GreenWave Advisors, the cannabis testing industry is expected to reach $850 million in size by 2020. The cannabis research firm also noted that cannabis testing services are the most attractive subsets of the cannabis industry, with the potential to expand its top- and bottom-line results through ancillary analytics and consulting services on top of bread-and-butter lab analysis services.
Read the entire press release here:
DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), was recently featured on GFarmaTV, a YouTube channel that covers the news, products, and lifestyle of the cannabis industry. In the video, DigiPath, Inc., CEO Todd Denkin offers an inside look at the cutting-edge cannabis testing facility in Las Vegas.
“It was exciting to have the GFarmaTV crew tour the DigiPath Labs facility,” says Denkin. “We put a lot of work into designing a state-of-the-art cannabis testing lab that provides reliable results, and it’s fun to let our patients, growers, and anyone who’s curious take a look at how we operate.”
In the video, Denkin explains how DigiPath Labs partners with growers to test medicinal cannabis in five-pound batches. He explains that the technicians perform a visual inspection and test for moisture, cannabinoid and terpenoid profiles, heavy metals, pesticides, and microbiological contamination. He also notes that DigiPath Labs tests oils, concentrates, shatters, and edibles.
The video also shows an increasingly popular DigiPath Labs offering: chemo profiling. This DNA testing method creates a digital representation of a particular strain, giving growers a way to distinguish and protect their specialized strains.
“Patents don’t work and trademarks don’t work for marijuana,” Denkin explains in the video, “but chemo profiling does work. So it is a good way to protect your strain simply by giving it a digital stamp, on a server, with a time and the exact profile.”
To view the DigiPath Labs GFarmaTV episode, visit https://www.youtube.com/watch?v=73Fc0wL2I_8&feature=youtu.be.
To learn more about DigiPath Labs, visit www.digipathlabs.com.
About DigiPath, Inc.
DigiPath, Inc., supports the cannabis industry’s best practices for reliable testing and education, and brings unbiased cannabis news coverage to the nation. DigiPath’s two business units are DigiPath Labs and TNM News Corp.
For more information, go to www.digipath.com.
Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s need for additional funding, governmental regulation of the cannabis industry, the demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.